Skip to main content
Weight Loss

6 CagriSema Side Effects You Should Know About

Stacia Woodcock, PharmDChristina Aungst, PharmD, MWC
Written by Stacia Woodcock, PharmD | Reviewed by Christina Aungst, PharmD, MWC
Published on November 19, 2026

Key takeaways:

  • CagriSema (cagrilintide / semaglutide) is a new injection that’s being studied for weight management and Type 2 diabetes. It combines two medications that work in different ways to reduce appetite and help people feel full.

  • The most common CagriSema side effects reported in clinical trials involve the digestive system. These include nausea, constipation, and stomach pain. Vomiting and diarrhea are also possible. These side effects tend to improve as you adjust to the medication.

  • More serious side effects are possible, including severe digestive problems and dehydration. Other potential risks, such as pancreatitis and gallbladder problems, are based partly on what’s known about semaglutide. CagriSema’s full safety profile is still being studied.

CagriSema is an investigational weight-loss medication. It combines cagrilintide, which targets amylin receptors, with semaglutide, which targets glucagon-like peptide-1 (GLP-1) receptors. These medications work together to reduce appetite and help you feel full longer.

CagriSema is a once-weekly injection that’s pending FDA approval for weight management and Type 2 diabetes. Clinical studies suggest that CagriSema can lead to significant weight loss. But like other medications that affect appetite and digestion, it can also cause side effects.

So, what are the most common CagriSema side effects? And are there any serious risks to know about? Here’s what clinical studies show so far.

1. Nausea and vomiting

Nausea is one of the most common CagriSema side effects reported in clinical studies. Vomiting can also happen, but it isn’t as common.

CagriSema can slow how quickly food moves out of your stomach. It also affects signals in your brain that control appetite and fullness. These effects can contribute to nausea, especially when you first start treatment or increase your dose.

Fortunately, nausea often improves as your body adjusts to treatment. You can also help reduce nausea by:

  • Eating smaller, more frequent meals

  • Avoiding greasy or fatty foods

  • Eating slowly and stopping when you feel full

  • Staying hydrated

  • Avoiding or limiting alcohol

If nausea becomes severe or doesn’t improve, let your healthcare team know. You may need a lower CagriSema dose to reduce this side effect. But if you are vomiting repeatedly or can’t keep liquids down, seek medical care right away. This isn’t typical, and it can lead to dehydration without proper treatment.

2. Constipation

Constipation is another reported side effect of CagriSema.

CagriSema can slow digestion. This may make bowel movements less frequent or harder to pass. Eating less food during treatment may also contribute to constipation.

Drinking plenty of water, staying physically active, and gradually increasing fiber intake can help keep bowel movements regular.

If constipation continues, ask your healthcare team whether an over-the-counter treatment, such as polyethylene glycol (Miralax), is appropriate.

Seek medical attention if you develop severe stomach pain, significant bloating, vomiting, or an inability to pass stool or gas. These symptoms could signal a more serious digestive problem.

3. Diarrhea

Some people also reported experiencing diarrhea in CagriSema clinical trials.

CagriSema slows stomach emptying, but it can still cause loose or frequent bowel movements for some people. Researchers are studying how the combination affects different parts of the digestive system.

If you develop diarrhea, drink plenty of fluids to replace what you’re losing. You can also try eating smaller meals and limiting greasy or fatty foods or any food that seems to worsen your symptoms.

Diarrhea from CagriSema is typically mild and improves over time. But severe or persistent diarrhea can lead to dehydration. Contact your healthcare team if diarrhea lasts more than a couple of days, becomes severe, or is accompanied by dizziness, weakness, or trouble keeping fluids down.

4. Stomach pain

Stomach pain and discomfort are other digestive side effects reported during CagriSema studies.

You may notice cramping, bloating, or a feeling of fullness after eating. These symptoms may be related to changes in how quickly food moves through your digestive system. Eating smaller portions and avoiding large, high-fat meals may help reduce discomfort.

Don’t ignore severe or persistent stomach pain. Medications that contain semaglutide can cause pancreatitis and gallbladder problems in rare cases. These conditions can cause severe abdominal pain, sometimes along with nausea or vomiting. If you develop severe stomach pain that doesn’t go away, especially if it spreads to your back, seek medical attention right away.

5. Injection site reactions

Since CagriSema is an injectable medication, it may cause redness, pain, or swelling in the area where you inject it. Typically, injection site reactions are mild and go away within a day or two. Following your prescriber’s instructions for injecting CagriSema, including changing injection sites, can help reduce discomfort.

If your symptoms don’t go away or become worse, seek medical care. These could be signs of an infection or a more serious skin reaction.

6. Serious CagriSema side effects

Serious CagriSema side effects seem to be rare. But information on serious risks is limited since it hasn’t been FDA approved.

Since it contains semaglutide, CagriSema likely carries a risk for:

  • Low blood glucose (sugar)

  • Pancreatitis

  • Gallbladder problems

  • Acute kidney damage

  • Vision changes

  • Severe low blood sugar

  • Gastroparesis (stomach paralysis)

  • Intestinal blockage

  • Increased risk of thyroid C-cell tumors

Your prescriber can discuss the risks and benefits of CagriSema based on your personal history once it’s approved by the FDA and its full prescribing information is available.

Frequently asked questions

Most digestive side effects reported in CagriSema clinical trials were temporary. They seem to be more common when starting CagriSema or after a dose increase and often improve over time. But how long they last can vary from person to person. Keep in mind that your prescriber may also be able to help address side effects by adjusting your dose.

Both CagriSema and Wegovy (semaglutide) can cause digestive side effects, such as nausea, vomiting, and constipation. CagriSema seems a bit more likely to cause these issues than semaglutide alone. But in most cases, stomach-related side effects from CagriSema are mild to moderate and go away over time. And there doesn’t seem to be a difference in serious side effects between the two medications.

No, it’s best to avoid compounded versions of CagriSema. The FDA states that cagrilintide, one of CagriSema’s active ingredients, cannot legally be used to make compounded medications in the U.S. And because CagriSema is still investigational, its full safety profile isn’t known. For these reasons, it’s safest to avoid compounded CagriSema products and receive CagriSema only through a legitimate clinical trial until it’s FDA approved.

The bottom line

CagriSema (cagrilintide / semaglutide) is an investigational weight-loss medication. Clinical studies show that the most common CagriSema side effects are nausea and vomiting, constipation, and stomach pain. Diarrhea is also possible. Most reported digestive side effects have been mild to moderate and go away over time as you adjust to the medication.

More serious side effects are possible, but CagriSema’s full safety profile is still being studied. Severe digestive symptoms, kidney problems, and low blood sugar are important concerns. Other potential risks, including pancreatitis and gallbladder problems, are partly based on what’s known about semaglutide. More information will become available as clinical trials continue and regulators review the medication.

why trust our exports reliability shield

Why trust our experts?

Stacia Woodcock, PharmD, is a pharmacy editor for GoodRx. She earned her Doctor of Pharmacy degree from the University of Kentucky and is licensed in New York and Massachusetts.
Christina Aungst, PharmD, MWC is a senior pharmacy editor for GoodRx. She began writing for GoodRx Health in 2019.

References

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Was this page helpful?

Latest articles